Year-End Termination

THE WASHINGTON GROUP for MENTOR CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$100,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Termination (this page) Feb 11, 2008 $100,000 Replaced
Year-End Termination Feb 11, 2008 $100,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring Legislative Process HR 2503 - FDA Scientific Fairness to Women Act - all provisions

LobbyistCovered position, as disclosed
KEVIN ALLEN N/A
CARLOS BONILLA N/A
MELISSA M EDWARDS N/A
KIMBERLEY FARMER N/A
RITA LEWIS —
PAUL LOBO N/A
MARISSA MITROVICH N/A
SUSAN MOLINARI N/A
JAMES NOONE N/A
G JOHN O'HANLON N/A
EUGENE PATRONE N/A
TONYA SAUNDERS N/A
BRETT SHOGREN POLICY DIRECTOR, OFFICE OF THE MAJORITY LEADER
HARRY SPORIDIS N/A
FOWLER WEST N/A

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2503 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.